Sponsors (5)
Introduced May 22, 2025 by Cindy Hyde-Smith · Last progress May 22, 2025
The bill increases federal support for restorative reproductive medicine, fertility‑awareness methods, data collection, training, and reimbursement—potentially improving diagnosis, provider capacity, and program transparency—but it also steers funding and incentives toward specific approaches with uncertain comparative effectiveness, raising costs, administrative burdens, privacy and access risks (including for ART and conventional family‑planning services).
Women and people with infertility will gain expanded access to restorative reproductive medicine, fertility‑awareness methods, and other non‑surgical options across federal programs, increasing care choices and potential for diagnosis and treatment.
Standardizing terms and eligibility (e.g., definitions of infertility, ART) makes program enrollment and coverage determinations clearer, helping people understand what services they can access and when.
New and updated procedure codes and bundled payment models create reimbursement that better reflects complex infertility diagnostics and coordinated care, incentivizing comprehensive, integrated treatment by providers.
Women and patients could lose access to established contraceptive and assisted reproductive services if federal definitions, funding priorities, or incentives prioritize restorative and fertility‑awareness approaches over other evidence‑based options.
Patients seeking assisted reproductive technologies (ART) may face reduced local access, delays, or travel burdens because the bill protects providers' conscience refusals to participate in ART in federally funded settings.
Taxpayers, public programs, insurers, and patients may face higher costs from expanded research, new reimbursements/bundles, added program funding, and potential insurer coverage expansions without identified offsets.
Based on analysis of 14 sections of legislative text.
Directs HHS to expand research, training, coding, survey items, and program eligibility to support restorative reproductive medicine, fertility-awareness methods, and male infertility education.
Directs HHS to expand research, training, data collection, diagnostic coding, and program eligibility to promote "restorative reproductive medicine," fertility awareness–based methods, and male infertility education. It requires updated training materials and Title X/Teen Pregnancy Prevention eligibility for organizations focused on restorative approaches, updates medical codes and payment models, mandates multiple reports and survey changes, and includes a federal conscience protection for providers who decline to participate in assisted reproductive technology (ART).